Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Respimat once-daily versus twice-daily dosing in moderate persistent asthma
2009-018006-21Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tiotropium in asthma (3 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Forced expiratory volume in one second. Started May 2010; status: completed.
02
Drugs
tiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on 2009-018006-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018006-21.